While most Big Pharma companies popped following the release of their first-quarter results, U.S. drug giant Merck (NYSE: MRK) hit the reverse button.
While most Big Pharma companies popped following the release of their first-quarter results, U.S. drug giant Merck (NYSE: MRK) hit the reverse button.